Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$17 1.8%
Market Cap
$67.8M
Price Target
Refer to Report
Volume
119.7K
52wk Range
$4.5601 - $76
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.